group (P < .01). Additionally, patients with stent graft rotation had significantly higher rates of type I and type III endoleaks (36% vs 9%; P < .05).
Objectives: The goal of this study was to identify the incidence of complications associated with upper extremity access in patients undergoing endovascular aortic repair (EVAR) at an regional aortic center.
Methods: Patients who had upper extremity access during EVAR were identified from 2013 to 2016. In-hospital and clinic records were reviewed to identify the indications for the upper extremity access, access techniques, and complications.
Results: Of 359 EVARs performed from 2013 to 2016, the upper extremity was used as access 72 times for 68 patients. Indication for upper extremity access was mostly for branch treatment in 46 (64%) and for establishing a brachiofemoral access in 24 (33%). Other indications included branch localization in 11 (15%), and difficult contralateral gate cannulation in 6 (8%). The brachial artery was used most frequently (n ¼ 61; 33 percutaneous, 28 by direct cutdown), followed by the axillary artery (n ¼ 7; 1 percutaneous, 6 by direct cutdown), with prior graft access or conduit creation occurring least often (n ¼ 4; 1 prior axillofemoral bypass, 2 new subclavian-carotid bypass, 1 new axillary-carotid bypass). Overall complication rate was 15.3% (11 of 72). Strokes were observed in three patients (4.2%), all who had a subclavian-carotid bypass or transposition. Local complications included seroma (axillary cutdown, n ¼ 1), hematoma (brachial cutdown, n ¼ 2; brachial percutaneous, n ¼ 2), transient peripheral neuropathy (brachial cutdown, n ¼ 1; brachial percutaneous, n ¼ 1), and local dissection leading to pseudoaneurysm (brachial percutaneous, n ¼ 1). Only one local complication required secondary intervention (hematoma evaluation after brachial percutaneous access with a 5F sheath). All other patients with access complications were managed nonoperatively, with complete symptom resolution. There was no statistical difference in complications between the different access techniques (P ¼ .359).
Conclusions: Local complications associated with upper extremity access during EVAR did not differ between access techniques. Strokes after upper extremity access occurred in patients with concomitant supra-aortic trunk reconstructions.
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Analysis and Quantification of Retained Air in Thoracic Aortic Endografts
Joel Gagnon, Jacques Tittley, Jonathan D. Misskey. University of British Columbia, Vancouver, British Colimbia, Canada
Objectives: Although the prevalence of stroke following TEVAR is well documented, the proportion of both clinically significant and silent air emboli during TEVAR remains undetermined. In addition, the amount of retained air present in a flushed and fully prepared aortic endograft has never been independently verified. The goal of this study was to determine the volume of air and the size of any macrobubbles released (diameter >1 mm) during standard aortic endograft deployment in an in vitro model.
Methods: A total of 11 endografts (8 Cook, 2 Gore, 1 Medtronic) were deployed within a custom-designed, sealed, and pressurized viewing chamber and recorded using a high-definition video camera. Endografts were deployed following standard instructions for use (IFU) preparation. Released air was measured using an air catch container, and bubble diameter was estimated using dedicated image processing software.
Results: All deployed endografts demonstrated retained air on deployment. Mean collected volume of air from endografts was 0.18 mL per endograft deployment (range, 0.125-0.225 mL). Macrobubbles >1 mm in diameter were observed in all grafts, with a mean bubble size of 2.59 mm (range, 1.07-5.21 mm). Macrobubbles were present in all Cook and Medtronic devices at the distal end of the delivery system (Fig) , whereas they were only found at the proximal end of the delivery system with Gore devices. The mean number of macrobubbles released per graft was 2.1 (range, 1-5).
Conclusions: A significant amount of air remains within aortic endografts following deployment in an in vitro model following standard and modified preparation. Additional study to determine the in vivo behavior of these bubbles is required to elucidate their potential for embolic events. 
